Nectar Lifesciences share news, announcements and annual reports
NSE: NECLIFEBSE: 532649Pharmaceuticals & BiotechnologySmall Cap
Nectar Lifesciences Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 2005
Last close ₹10.20down ₹0.13 (1.26%)BSE ₹10.29
Share price at the NSE close on 30 Oct 2026. Previous close ₹10.33.
30 Oct: open ₹10.43, high ₹10.43, low ₹9.82
52-week range of traded prices to 30 Oct 2026
₹9.30Low, 30 Mar 2026₹22.40High, 23 Dec 2025
- Under NSE's long-term additional surveillance, stage I, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹198 Cr2,221st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.34
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −31.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹171 crore of one-off items, the largest of them in the quarter to Sep 2025.
- −9.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −15.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 95,05079.2% delivered
Nectar Lifesciences board meetings
117 filed, newest first. Page 2 of 3.
Aug 2019
14 Aug · Board meeting
May 2019
Feb 2019
12 Feb · Board meeting
Nov 2018
Aug 2018
7 Aug · Board meeting
Jul 2018
May 2018
Feb 2018
Nov 2017
Aug 2017
Jun 2017
27 Jun · Board meeting
21 Jun · Board meeting
To consider and approve, inter alia amongst items: 1. The Audited Financial Results for the Financial Year 2016-17, Financial Statements of the Company for the Financial Year 2016-17 and matters related thereto. 2. Recommendation of final dividend to the Members of the Company for Financial Year 2016-17. The Original Meeting was held on May 30, 2017 and adjourned for above matters due to certain exigencies. Further, pursuant to Code of Conduct as per Regulation 9 of Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, Company wish to inform the Exchange that the trading window of the Company shall stand closed from June 21, 2017 to June 29, 2017 (both days inclusive).
May 2017
30 May · Board meeting
Feb 2017
Dec 2016
Aug 2016
May 2016
Feb 2016
Nov 2015
16 Nov · Board meeting
Aug 2015
May 2015
Feb 2015
4 Feb · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial Results of the company for the period ended on December 31, 2014.
Nov 2014
4 Nov · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial Results of the company for the period ended on September 30, 2014.
Jul 2014
May 2014
19 May · Board meeting
To consider and approve, inter alia amongst items,: 1. The Audited Financial Results for Financial Year 2013-14, Balance Sheet of the company as at 31.03.2014 and Profit & Loss Accounts for the financial year ended on 31.03.2014 and matters related thereto. 2. Recommendation of final dividend to the Members of the company for Financial Year 2013-14.
Feb 2014
Nov 2013
5 Nov · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial (Provisional) Results of the company for the quarter/ half year ended on September 30, 2013.
Aug 2013
5 Aug · Board meeting
To consider and approve, inter alia amongst items : (1) The Unaudited Financial Results of the company for the quarter ended on June 30, 2013; (2) To convene the Annual General Meeting of Members of the Company for the Financial Year 2012-13 and matters related thereto; (3) To fix the Book closure dates and for the purpose of Annual General Meeting and Dividend, as recommended by the Board Directors in their last Meeting.
May 2013
6 May · Board meeting
Inter alia, to consider and approve the following: (1) The Audited Financial Results for Financial Year 2012-13, Balance Sheet of the Company as at March 31, 2013 and Profit A Loss Accounts for the financial year ended on March 31, 2013 and matters related thereto, (2) Recommendation of final dividend to the Members of the Company for Financial Year 2012-13.
Feb 2013
5 Feb · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial Results of the Company for the quarter ended on December 31, 2012.
Oct 2012
25 Oct · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial Results of the Company for the period ended on September 30, 2012.
Aug 2012
10 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 09, 2012, have inter alia decided and approved : (1) To commence a new business regarding 'Manufacturing and Processing of Agro based Products' more specifically provided in other objects No. 21, 22 and 23 of Memorandum and Articles of Association of the Company and proposed a special Resolution under Section 149(2A) of the Companies Act, 1956 in the forthcoming Annual General Meeting.1 Aug · Board meeting
To consider and approve, inter alia amongst items, : (1) The Unaudited Financial Results of the Company for the quarter ended on June 30, 2012; (2) The Audited Financial Results for Financial Year 2011-12, Balance Sheet of the Company as at March 31, 2012 and Profit & Loss Accounts for the financial year ended on March 31, 2012 and matters related thereto; (3) To convene the Annual General Meeting of Members of the Company for the financial Year 2011-12 and matters related thereto.(4)Recommendation of final dividend to the Members of the company for Financial Year 2011-12 and fix the Book closure dates and matters related thereto.
May 2012
5 May · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial Results of the Company for the quarter ended on March 31, 2012.
Feb 2012
1 Feb · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial Results of the Company for the quarter ended on December 31, 2011.
Oct 2011
31 Oct · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial Results of the Company for the quarter ended on September 30, 2011.
Aug 2011
4 Aug · Board meeting
To consider and approve, inter alia amongst items, : (1) The Unaudited Financial Results of the Company for the quarter ended on June 30, 2011; (2) The Audited Financial Results for Financial Year 2010-11, Balance Sheet of the Company as at March 31, 2011 and Profit & Loss Accounts for the financial year ended on March 31, 2011 and matters related thereto; (3) To convene the Annual General Meeting of Members of the Company for the financial Year 2010-11 and matters related thereto.
May 2011
3 May · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial Results of the Company for the quarter ended on March 31, 2011.
Jan 2011
4 Jan · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial Results of the Company for the quarter ended on December 31, 2010.
Oct 2010
28 Oct · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial Results of the Company for the quarter ended on September 30, 2010.
Jul 2010
31 Jul · Board meeting
To consider, interalia amongst other items, the unaudited financial results of the company for the quarter ended on June 30, 2010.
May 2010
28 May · Board meeting
Board of Directors in their meeting held on May 28, 2010 have decided to fix the date of Annual General Meeting and matter related thereto in next Board Meeting.19 May · Board meeting
To consider and approve inter-alia amongst items: (1) The Audited Financial Results for Financial Year 2009-10, Balance Sheet of the Company as at March 31, 2010 and Profit & Loss Accounts for the financial year ended on March 31, 2010 and matters related thereto. (2) The date of Annual General Meeting of Members of the Company for the Financial Year 2009-10 and matters related thereto.
Jan 2010
13 Jan · Board meeting
To consider, inter alia amongst other items, declaration of interim dividend to the equity shareholders of the company for Financial Year 2009-10. Further, the Company has fixed the January 22, 2010 as the record date to ascertain the name of shareholders for entitlement of Interim Dividend, if declared, by the Board of Directors in their meeting scheduled to be held on January 15, 2010.13 Jan · Board meeting
Board of Directors in their meeting held on January 12, 2010 has approved the followings: (1) Issuance of upto 26,000,000 equity shares of the Company on a preferential basis to NSR Direct PE Mauritius, LLC and/or its affiliates; (2) Issuance of GDRs/ADRs/FCCBs/QIP/fully or partially Convertible Debentures/ any other instrument or any other international offering of upto Rs.250 Crores; (3) To seek approval of shareholders for the above purposes u/s 81(1A) of the Companies Act, 1956, an Extra-Ordinary General Meeting of the Company is proposed to be convened on February 11, 2010.